Company Filing History:
5 out of 1,970 
4 out of 152 
1 out of 1,624 
Years Active: 2008-2017
Title: Chris Vezina: Innovator in Monoclonal Antibody Development
Introduction
Chris Vezina is a prominent inventor based in Newbury Park, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic monoclonal antibodies. With a total of 5 patents, Vezina's work has the potential to impact the treatment of various diseases.
Latest Patents
Among his latest patents is the therapeutic human anti-IL-1R1 monoclonal antibody. This patent describes antibodies that interact with interleukin-1 receptor type 1 (IL-1R1). The methods outlined include treating IL-1 mediated diseases by administering a pharmaceutically effective amount of these antibodies. Additionally, the patent details methods for detecting the amount of IL-1R1 in a sample using antibodies to IL-1R1.
Career Highlights
Chris Vezina has worked with notable companies in the biotechnology sector, including Amgen Inc. and Medarex Inc. His experience in these organizations has allowed him to refine his expertise in antibody development and therapeutic applications.
Collaborations
Some of his coworkers include Brian C Varnum and Alison Witte. Their collaborative efforts have contributed to advancements in the field of monoclonal antibodies.
Conclusion
Chris Vezina's innovative work in the development of therapeutic antibodies showcases his commitment to advancing medical science. His contributions are poised to make a significant impact on the treatment of IL-1 mediated diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.